To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 1,397.00 <%= Resources.Global.txtDown %>
Updated 10:08:43
Change % -1.90% Stock price decreasing
Change -27.00 Stock price decreasing
Volume 256,625
High DKK 1,421.00
Low DKK 1,391.00
Open DKK 1,421.00
ISIN DK0010272202
Prev close DKK 1,424.00
# of shares 60.35M
Market cap 84,309M DKK
Intraday

Genmab A/S
Market is open (until 16:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,397.00 -0.7% Stock price decreasing 8.5% Stock price increasing 13.9% Stock price increasing 24.1% Stock price increasing 79.3% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

News about Genmab A/S

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 52.15 71.0% Stock price increasing 71.0% Stock price increasing 71.0% Stock price increasing 71.0% Stock price increasing 71.0% Stock price increasing 71.0% Stock price increasing
 
Bristol-Myers Squibb Company 55.77 2.2% Stock price increasing 13.9% Stock price increasing -1.7% Stock price decreasing -4.8% Stock price decreasing -10.4% Stock price decreasing -4.6% Stock price decreasing
 
Johnson & Johnson 121.70 2.4% Stock price increasing 8.9% Stock price increasing 7.6% Stock price increasing 2.5% Stock price increasing 15.9% Stock price increasing 5.6% Stock price increasing
 
Pfizer Inc 34.06 1.3% Stock price increasing 9.3% Stock price increasing 8.4% Stock price increasing -2.2% Stock price decreasing 13.5% Stock price increasing 4.9% Stock price increasing
 
Amgen Inc 174.01 0.4% Stock price increasing 14.6% Stock price increasing 20.0% Stock price increasing 1.9% Stock price increasing 18.3% Stock price increasing 19.0% Stock price increasing
 
Bavarian Nordic A/S 285.00 3.8% Stock price increasing 5.6% Stock price increasing 30.1% Stock price increasing 15.4% Stock price increasing 11.3% Stock price increasing 14.5% Stock price increasing
 
Merck Kgaa O.N. 103.00 1.6% Stock price increasing 2.5% Stock price increasing 9.1% Stock price increasing 6.3% Stock price increasing 37.3% Stock price increasing 3.9% Stock price increasing
 
Novartis NAM SF 0,50 72.76 0.6% Stock price increasing 12.4% Stock price increasing 11.9% Stock price increasing 1.0% Stock price increasing 10.2% Stock price increasing 5.3% Stock price increasing
 
Roche Hldg AG GEN 229.70 -0.1% Stock price decreasing 6.6% Stock price increasing 9.3% Stock price increasing 2.8% Stock price increasing -0.1% Stock price decreasing 6.2% Stock price increasing
 
Biogen Inc 284.75 -1.5% Stock price decreasing 4.0% Stock price increasing -6.9% Stock price decreasing -7.9% Stock price decreasing 10.7% Stock price increasing 0.4% Stock price increasing
 
Emergent Biosolutions Inc 29.78 -2.0% Stock price decreasing -0.6% Stock price decreasing 0.8% Stock price increasing 10.1% Stock price increasing -20.3% Stock price decreasing -9.3% Stock price decreasing
 
Bayer AG NA O.N. 105.40 -1.0% Stock price decreasing 3.9% Stock price increasing 18.8% Stock price increasing 9.0% Stock price increasing 11.2% Stock price increasing 6.3% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,072.95 -0.3% Stock price decreasing 4.3% Stock price increasing 12.0% Stock price increasing 3.3% Stock price increasing 12.3% Stock price increasing 5.2% Stock price increasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 CAP 1,072.95 -0.4% Stock price decreasing
100,67,75,63,45,28,6,3,21,0
Instruments Last Change  
Eisai CO Ltd 52.15 1.2% Stock price increasing
0,0,0,0,0,0,0,0,0,0
Bristol-Myer.. 55.77 0.0% Stock price unchanged
31,38,17,7,61,80,60,88,88,81
Johnson & Jo.. 121.70 0.7% Stock price increasing
0,17,35,58,71,70,86,100,98,95
Pfizer Inc 34.06 0.0% Stock price unchanged
0,53,32,72,91,87,89,96,92,90
Amgen Inc 174.01 0.0% Stock price unchanged
30,29,12,45,69,59,74,71,78,100
Bavarian Nor.. 285.00 1.8% Stock price increasing
12,25,37,50,56,68,87,93,87,75
Merck Kgaa O.. 103.00 0.2% Stock price increasing
83,50,58,58,75,83,58,83,83,75
Novartis NAM.. 72.76 -0.3% Stock price decreasing
85,88,94,91,58,70,58,76,35,20
Roche Hldg A.. 229.70 -0.2% Stock price decreasing
15,25,75,65,50,35,50,55,35,25
Biogen Inc 284.75 0.0% Stock price unchanged
100,22,6,32,35,11,3,35,22,29
Emergent Bio.. 29.78 0.0% Stock price unchanged
65,80,40,37,40,23,13,32,60,49
Bayer AG NA .. 105.40 0.3% Stock price increasing
88,11,35,23,64,29,47,47,58,82

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/JPMorgan: Hæver kursmål til 1500 kr.
JPMorgan
1,500 op
Yesterday
Genmab/Goldman: Kursmålet hæves til 1370 kr.
Goldman Sachs
1,370
17/01/17
Genmab/ABG: Løfter kursmål med 400 kr. til 1500 kr.
ABG Sundal Collier
1,500 op
07/06/16
KORR: Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Citi: Hæver kursmål til 1460 kr. fra 1140 kr.
Citigroup
1,460 op
07/06/16
Genmab/Danske: Løfter kursmål til 1300 kr. fra 1145 kr.
Danske Bank
1,300 op
23/05/16

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 February 2017 10:23:59
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170217.2 - EUROWEB5 - 2017-02-24 11:23:59 - 2017-02-24 10:23:59 - 1000 - Website: OKAY